Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Perego, Carlo ^a   Fumagalli, Stefano ^a   De Simoni, Maria Grazia ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Alternative activation; Inflammation; Stroke

Indexed keywords

CARBOHYDRATE BINDING PROTEIN; CD11B ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; PROTEIN CD206; PROTEIN YM1; SECRETORY PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; BRAIN SIZE; CELL ACTIVATION; CELL COUNT; CELL SUBPOPULATION; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; GENE EXPRESSION PROFILING; GENE LOCATION; MACROPHAGE; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROANATOMY; NEUROPATHOLOGY; NONHUMAN; PROTEIN LOCALIZATION; ANIMAL; BRAIN INJURY; C57BL MOUSE; CEREBRAL ARTERY DISEASE; CYTOLOGY; METABOLISM; NICK END LABELING; PATHOLOGY; PHENOTYPE; TIME;

ANIMALS; BIOLOGICAL MARKERS; BRAIN INJURIES; BRAIN ISCHEMIA; IN SITU NICK-END LABELING; INFARCTION, MIDDLE CEREBRAL ARTERY; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; PHENOTYPE; TIME FACTORS;

EID: 83055181916     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-174     Document Type: Article

References (52)

1. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005, 8:752-758. 10.1038/nn1472, 15895084.
2. Yenari MA, Kauppinen TM, Swanson RA. Microglial activation in stroke: therapeutic targets. Neurotherapeutics 2010, 7:378-391. 10.1016/j.nurt.2010.07.005, 20880502.
3. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med 2011, 17:796-808. 10.1038/nm.2399, 21738161.
4. Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 2010, 87:779-789. 10.1189/jlb.1109766, 2858674, 20130219.
5. Schilling M, Besselmann M, Muller M, Strecker JK, Ringelstein EB, Kiefer R. Predominant phagocytic activity of resident microglia over hematogenous macrophages following transient focal cerebral ischemia: an investigation using green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 2005, 196:290-297. 10.1016/j.expneurol.2005.08.004, 16153641.
6. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007, 8:57-69. 10.1038/nrn2038, 17180163.
7. Hanisch UK. Microglia as a source and target of cytokines. Glia 2002, 40:140-155. 10.1002/glia.10161, 12379902.
8. Capone C, Frigerio S, Fumagalli S, Gelati M, Principato MC, Storini C, Montinaro M, Kraftsik R, De Curtis M, Parati E, De Simoni MG. Neurosphere-derived cells exert a neuroprotective action by changing the ischemic microenvironment. PLoS ONE 2007, 2:e373. 10.1371/journal.pone.0000373, 1847533, 17440609.
9. Lalancette-Hebert M, Gowing G, Simard A, Weng YC, Kriz J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 2007, 27:2596-2605. 10.1523/JNEUROSCI.5360-06.2007, 17344397.
10. Neumann J, Gunzer M, Gutzeit HO, Ullrich O, Reymann KG, Dinkel K. Microglia provide neuroprotection after ischemia. Faseb J 2006, 20:714-716.
11. Nakajima K, Yamamoto S, Kohsaka S, Kurihara T. Neuronal stimulation leading to upregulation of glutamate transporter-1 (GLT-1) in rat microglia in vitro. Neurosci Lett 2008, 436:331-334. 10.1016/j.neulet.2008.03.058, 18406522.
12. Stoll G, Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol 1999, 58:233-247. 10.1016/S0301-0082(98)00083-5, 10341362.
13. Thored P, Heldmann U, Gomes-Leal W, Gisler R, Darsalia V, Taneera J, Nygren JM, Jacobsen SE, Ekdahl CT, Kokaia Z, Lindvall O. Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia 2009, 57:835-849. 10.1002/glia.20810, 19053043.
14. Lu YZ, Lin CH, Cheng FC, Hsueh CM. Molecular mechanisms responsible for microglia-derived protection of Sprague-Dawley rat brain cells during in vitro ischemia. Neurosci Lett 2005, 373:159-164. 10.1016/j.neulet.2004.10.004, 15567573.
15. Batchelor PE, Liberatore GT, Wong JY, Porritt MJ, Frerichs F, Donnan GA, Howells DW. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 1999, 19:1708-1716.
16. David S, Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 2011, 12:388-399. 10.1038/nrn3053, 21673720.
17. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D, Dieli F, Ghisletti S, Natoli G, De Baetselier P, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci USA 2009, 106:14978-14983. 10.1073/pnas.0809784106, 2736429, 19706447.
18. Michelucci A, Heurtaux T, Grandbarbe L, Morga E, Heuschling P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol 2009, 210:3-12. 10.1016/j.jneuroim.2009.02.003, 19269040.
19. Penninger JM, Irie-Sasaki J, Sasaki T, Oliveira-dos-Santos AJ. CD45: new jobs for an old acquaintance. Nat Immunol 2001, 2:389-396.
20. Bhatia S, Fei M, Yarlagadda M, Qi Z, Akira S, Saijo S, Iwakura Y, van Rooijen N, Gibson GA, St Croix CM, et al. Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype. PLoS One 2011, 6:e15943. 10.1371/journal.pone.0015943, 3016416, 21246055.
21. Raes G, Noel W, Beschin A, Brys L, de Baetselier P, Hassanzadeh GH. FIZZ1 and Ym as tools to discriminate between differentially activated macrophages. Dev Immunol 2002, 9:151-159. 10.1080/1044667031000137629, 2276098, 12892049.
22. Gesuete R, Storini C, Fantin A, Stravalaci M, Zanier ER, Orsini F, Vietsch H, Mannesse ML, Ziere B, Gobbi M, De Simoni MG. Recombinant C1 inhibitor in brain ischemic injury. Ann Neurol 2009, 66:332-342. 10.1002/ana.21740, 19798727.
23. Storini C, Bergamaschini L, Gesuete R, Rossi E, Maiocchi D, De Simoni MG. Selective inhibition of plasma kallikrein protects brain from reperfusion injury. J Pharmacol Exp Ther 2006, 318:849-854. 10.1124/jpet.106.105064, 16705080.
24. De Simoni MG, Storini C, Barba M, Catapano L, Arabia AM, Rossi E, Bergamaschini L. Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia. J Cereb Blood Flow Met 2003, 23:232-239.
25. Swanson R, Morton M, Tsao-Wu G, Savalos R, Davidson C, Sharp F. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990, 10:290-293. 10.1038/jcbfm.1990.47, 1689322.
26. Donnelly DJ, Gensel JC, Ankeny DP, van Rooijen N, Popovich PG. An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology. J Neurosci Methods 2009, 181:36-44. 10.1016/j.jneumeth.2009.04.010, 2737682, 19393692.
27. Ortolano F, Colombo A, Zanier ER, Sclip A, Longhi L, Perego C, Stocchetti N, Borsello T, De Simoni MG. c-Jun N-terminal kinase pathway activation in human and experimental cerebral contusion. J Neuropathol Exp Neurol 2009, 68:964-971. 10.1097/NEN.0b013e3181b20670, 19680147.
28. Longhi L, Gesuete R, Perego C, Ortolano F, Sacchi N, Villa P, Stocchetti N, De Simoni MG. Long-lasting protection in brain trauma by endotoxin preconditioning. J Cereb Blood Flow Metab 2011,
29. Santosh C, Brennan D, McCabe C, Macrae IM, Holmes WM, Graham DI, Gallagher L, Condon B, Hadley DM, Muir KW, Gsell W. Potential use of oxygen as a metabolic biosensor in combination with T2*-weighted MRI to define the ischemic penumbra. J Cereb Blood Flow Metab 2008, 28:1742-1753. 10.1038/jcbfm.2008.56, 3119432, 18545262.
30. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39:175-191. 10.3758/BF03193146, 17695343.
31. Sedgwick JD, Schwender S, Imrich H, Dorries R, Butcher GW, ter Meulen V. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci USA 1991, 88:7438-7442. 10.1073/pnas.88.16.7438, 52311, 1651506.
32. Stein VM, Baumgartner W, Schroder S, Zurbriggen A, Vandevelde M, Tipold A. Differential expression of CD45 on canine microglial cells. J Vet Med A Physiol Pathol Clin Med 2007, 54:314-320. 10.1111/j.1439-0442.2007.00926.x, 17650152.
33. Colton CA. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009, 4:399-418. 10.1007/s11481-009-9164-4, 2773116, 19655259.
34. Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, Haugaard LS, Wirenfeldt M, Nielsen M, Dagnaes-Hansen F, et al. Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci 2009, 29:1319-1330. 10.1523/JNEUROSCI.5505-08.2009, 19193879.
35. Reed-Geaghan EG, Reed QW, Cramer PE, Landreth GE. Deletion of CD14 attenuates Alzheimer's disease pathology by influencing the brain's inflammatory milieu. J Neurosci 2011, 30:15369-15373.
36. Shin JW, Lee JK, Lee JE, Min WK, Schuchman EH, Jin HK, Bae JS. Combined Effects of Hematopoietic Progenitor Cell Mobilization from Bone Marrow by Granulocyte Colony Stimulating Factor and AMD3100 and Chemotaxis into the Brain Using Stromal Cell-Derived Factor-1alpha in an Alzheimer's Disease Mouse Model. Stem Cells 2011, 29:1075-1089. 10.1002/stem.659, 21608078.
37. Ohtaki H, Ylostalo JH, Foraker JE, Robinson AP, Reger RL, Shioda S, Prockop DJ. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci USA 2008, 105:14638-14643. 10.1073/pnas.0803670105, 2567180, 18794523.
38. Ponomarev ED, Maresz K, Tan Y, Dittel BN. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 2007, 27:10714-10721. 10.1523/JNEUROSCI.1922-07.2007, 17913905.
39. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009, 29:13435-13444. 10.1523/JNEUROSCI.3257-09.2009, 2788152, 19864556.
40. Solovjov DA, Pluskota E, Plow EF. Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2. J Biol Chem 2005, 280:1336-1345.
41. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA, Arumugam TV, Orthey E, Gerloff C, Tolosa E, Magnus T. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40:1849-1857. 10.1161/STROKEAHA.108.534503, 19265055.
42. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci 2011, 14:1142-1149. 10.1038/nn.2887, 21804537.
43. de Beer MC, Zhao Z, Webb NR, van der Westhuyzen DR, de Villiers WJ. Lack of a direct role for macrosialin in oxidized LDL metabolism. J Lipid Res 2003, 44:674-685. 10.1194/jlr.M200444-JLR200, 12562841.
44. Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci USA 1996, 93:14833-14838. 10.1073/pnas.93.25.14833, 26222, 8962141.
45. Jayadev S, Nesser NK, Hopkins S, Myers SJ, Case A, Lee RJ, Seaburg LA, Uo T, Murphy SP, Morrison RS, Garden GA. Transcription factor p53 influences microglial activation phenotype. Glia 2011, 59:1402-1413. 10.1002/glia.21178, 21598312.
46. Denes A, Vidyasagar R, Feng J, Narvainen J, McColl BW, Kauppinen RA, Allan SM. Proliferating resident microglia after focal cerebral ischaemia in mice. J Cereb Blood Flow Metab 2007,
47. Zanier ER, Montinaro M, Vigano M, Villa P, Fumagalli S, Pischiutta F, Longhi L, Leoni ML, Rebulla P, Stocchetti N, et al. Human umbilical cord blood mesenchymal stem cells protect mice brain after trauma. Crit Care Med 2011,
48. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40. 10.1038/35065000, 11242034.
49. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, Dereuddre-Bosquet N, Dormont D, Gras G. Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 2005, 142:481-489. 1809537, 16297160.
50. Linehan JD, Kolios G, Valatas V, Robertson DA, Westwick J. Immunomodulatory cytokines suppress epithelial nitric oxide production in inflammatory bowel disease by acting on mononuclear cells. Free Radic Biol Med 2005, 39:1560-1569. 10.1016/j.freeradbiomed.2005.07.019, 16298681.
51. Sierra A, Encinas JM, Deudero JJ, Chancey JH, Enikolopov G, Overstreet-Wadiche LS, Tsirka SE, Maletic-Savatic M. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 7:483-495.
52. Kettenmann H. Neuroscience: the brain's garbage men. Nature 2007, 446:987-989. 10.1038/nature05713, 17410127.